$5.80
0.173.02%
Pre-Market: 9:02 AM EDT
Comments
Loading...
Xeris Biopharma Holdings Earnings Estimates, EPS & Revenue | NASDAQ:XERS | Benzinga
Xeris Biopharma Holdings reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 8
EPS Estimate
$-0.030
Quarterly Revenue Estimate
$54.90M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$203.07M
Analyze the earnings history of Xeris Biopharma Holdings using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| XERS | Xeris Biopharma Holdings | -$0.14 | -$0.03 | — | — | $40.64M | $54.90M | — | — | 05/08/2025 | Get Alert |
| XERS | Xeris Biopharma Holdings | -$0.10 | -$0.02 | -$0.03 | -50.00% | $44.39M | $58.54M | $60.10M | 2.66% | 03/06/2025 | Get Alert |
| XERS | Xeris Biopharma Holdings | -$0.09 | -$0.09 | -$0.11 | -22.22% | $48.32M | $51.43M | $54.27M | 5.52% | 11/08/2024 | Get Alert |
| XERS | Xeris Biopharma Holdings | -$0.14 | -$0.11 | -$0.10 | 9.09% | $36.89M | $45.81M | $46.51M | 1.53% | 08/08/2024 | Get Alert |
| XERS | Xeris Biopharma Holdings | -$0.12 | -$0.12 | -$0.14 | -16.67% | $33.20M | $41.81M | $40.64M | -2.80% | 05/09/2024 | Get Alert |
| XERS | Xeris Biopharma Holdings | -$0.10 | -$0.10 | -$0.10 | 0.00% | $33.14M | $43.55M | $44.39M | 1.93% | 03/06/2024 | Get Alert |
| XERS | Xeris Biopharma Holdings | -$0.16 | -$0.12 | -$0.09 | 25.00% | $29.73M | $41.08M | $48.32M | 17.62% | 11/09/2023 | Get Alert |
| XERS | Xeris Biopharma Holdings | -$0.19 | -$0.13 | -$0.14 | -7.69% | $25.26M | $34.84M | $36.89M | 5.89% | 08/08/2023 | Get Alert |
| XERS | Xeris Biopharma Holdings | -$0.25 | -$0.17 | -$0.12 | 29.41% | $22.07M | $30.76M | $33.20M | 7.92% | 05/09/2023 | Get Alert |
| XERS | Xeris Biopharma Holdings | -$0.42 | -$0.16 | -$0.10 | 37.50% | $21.43M | $31.04M | $33.14M | 6.78% | 03/08/2023 | Get Alert |
| XERS | Xeris Biopharma Holdings | -$0.39 | -$0.16 | -$0.16 | 0.00% | $11.04M | $29.12M | $29.73M | 2.08% | 11/09/2022 | Get Alert |
| XERS | Xeris Biopharma Holdings | -$0.41 | -$0.20 | -$0.19 | 5.00% | $8.84M | $25.53M | $25.26M | -1.06% | 08/10/2022 | Get Alert |
| XERS | Xeris Biopharma Holdings | -$0.30 | -$0.25 | -$0.25 | 0.00% | $8.05M | $23.59M | $21.91M | -7.12% | 05/11/2022 | Get Alert |
| XERS | Xeris Biopharma Holdings | -$0.41 | -$0.24 | -$0.42 | -75.00% | $7.09M | $18.90M | $21.43M | 13.38% | 03/10/2022 | Get Alert |
| XERS | Xeris Biopharma Holdings | -$0.35 | -$0.37 | -$0.39 | -5.41% | $9.45M | $11.03M | $11.04M | 0.05% | 11/10/2021 | Get Alert |
| XERS | Xeris Biopharma Holdings | -$0.63 | -$0.30 | -$0.41 | -36.67% | $2.03M | $9.54M | $8.84M | -7.39% | 08/05/2021 | Get Alert |
| XERS | Xeris Biopharma Holdings | -$0.89 | -$0.34 | -$0.30 | 11.76% | $1.79M | $7.47M | $8.05M | 7.78% | 05/13/2021 | Get Alert |
| XERS | Xeris Biopharma Holdings | -$1.23 | -$0.38 | -$0.41 | -7.89% | $1.86M | $8.21M | $7.09M | -13.65% | 03/09/2021 | Get Alert |
| XERS | Xeris Biopharma Holdings | -$1.22 | -$0.52 | -$0.35 | 32.69% | $314.00K | $4.48M | $9.45M | 110.89% | 11/09/2020 | Get Alert |
| XERS | Xeris Biopharma Holdings | -$1.28 | -$0.73 | -$0.63 | 13.70% | $320.00K | $1.86M | $2.03M | 8.98% | 08/10/2020 | Get Alert |
| XERS | Xeris Biopharma Holdings | -$1.07 | -$0.89 | -$0.89 | 0.00% | $248.00K | $1.43M | $1.79M | 25.03% | 05/07/2020 | Get Alert |
Xeris Biopharma Holdings (XERS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-06 | $-0.03 | $-0.02 | -50.0 % |
| Q3 | 2024-11-08 | $-0.11 | $-0.09 | -22.2 % |
| Q2 | 2024-08-08 | $-0.10 | $-0.11 | 9.09 % |
| Q1 | 2024-05-09 | $-0.14 | $-0.12 | -16.7 % |
Xeris Biopharma Holdings (XERS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-06 | $60.10M | $58.54M | 2.66 % |
| Q3 | 2024-11-08 | $54.27M | $51.43M | 5.52 % |
| Q2 | 2024-08-08 | $46.51M | $45.81M | 1.53 % |
| Q1 | 2024-05-09 | $40.64M | $41.81M | -2.80 % |
FAQ
When is Xeris Biopharma Holdings (NASDAQ:XERS) reporting earnings?
Xeris Biopharma Holdings (XERS) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on March 6, 2025 for Q4.
What were the latest earnings per share (EPS) for Xeris Biopharma Holdings (NASDAQ:XERS)?
The Actual EPS was $-0.03, which missed the estimate of $-0.02.
What were Xeris Biopharma Holdings’s (NASDAQ:XERS) revenues?
The Actual Revenue was $60.1M, which beat the estimate of $58.5M.
Browse earnings estimates, EPS, and revenue on all stocks.